Want to join the conversation?
$ABT's R&D expenses increased by 23.7% in 3Q15, due primarily to higher spending across its various businesses and the impact of higher restructuring costs recorded in the quarter. SG&A expenses for 3Q15 increased 4.5%, due primarily to the impact of the acquisition of CFR Pharmaceuticals in 3Q14 and Veropharm in 4Q14.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.